China has initially established early resolution mechanism of patent disputes (ERMPD) for biologics, but it is not yet complete. On the basis of clarifying the definition, function, type of the mechanism and content of typical national mechanism, this paper discusses the influencing factors of mode selection, so as to provide references for China to improve the ERMPD for biologics in the future. The present complete ERMPD for biologics can be divided into “soft linkage mode” and “hard linkage mode”. The model selection affected by factors such as mode function, industrial development, patent protection features, and international trade strategy. It is suggested that when improving the ERMPD for biologics in the future, China should combine the above factors and choose an institutional model that is more suitable for its national conditions.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |